Status of work
In April, AOTMiT begins work on orders from the Minister of Health:
- Omvoh (mirikizumab) for the treatment of patients with Crohn’s disease
- Amvuttra (vutrisiran) for the treatment of patients with cardiomyopathy
- Cabometyx (cabozantinib) for use in chemotherapy
- Dupixent (dupilumab) for the treatment of patients with chronic obstructive pulmonary disease
The listed order is available on the AOTMiT Public Information Bulletin.